Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.
Yofe I, Shami T, Cohen N, Landsberger T, Sheban F, Stoler-Barak L, Yalin A, Phan TS, Li B, Monteran L, Scharff Y, Giladi A, Elbaz M, David E, Gurevich-Shapiro A, Gur C, Shulman Z, Erez N, Amit I. Yofe I, et al. Among authors: yalin a. Cancer Discov. 2023 Dec 12;13(12):2610-2631. doi: 10.1158/2159-8290.CD-23-0299. Cancer Discov. 2023. PMID: 37756565
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.
McFarland AP, Yalin A, Wang SY, Cortez VS, Landsberger T, Sudan R, Peng V, Miller HL, Ricci B, David E, Faccio R, Amit I, Colonna M. McFarland AP, et al. Among authors: yalin a. Immunity. 2021 Jun 8;54(6):1320-1337.e4. doi: 10.1016/j.immuni.2021.03.024. Epub 2021 May 3. Immunity. 2021. PMID: 33945787 Free PMC article.
Single-cell immunology: Past, present, and future.
Ginhoux F, Yalin A, Dutertre CA, Amit I. Ginhoux F, et al. Among authors: yalin a. Immunity. 2022 Mar 8;55(3):393-404. doi: 10.1016/j.immuni.2022.02.006. Immunity. 2022. PMID: 35263567 Free article. Review.
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Gur C, Wang SY, Sheban F, Zada M, Li B, Kharouf F, Peleg H, Aamar S, Yalin A, Kirschenbaum D, Braun-Moscovici Y, Jaitin DA, Meir-Salame T, Hagai E, Kragesteen BK, Avni B, Grisariu S, Bornstein C, Shlomi-Loubaton S, David E, Shreberk-Hassidim R, Molho-Pessach V, Amar D, Tzur T, Kuint R, Gross M, Barboy O, Moshe A, Fellus-Alyagor L, Hirsch D, Addadi Y, Erenfeld S, Biton M, Tzemach T, Elazary A, Naparstek Y, Tzemach R, Weiner A, Giladi A, Balbir-Gurman A, Amit I. Gur C, et al. Among authors: yalin a. Cell. 2022 Apr 14;185(8):1373-1388.e20. doi: 10.1016/j.cell.2022.03.011. Epub 2022 Apr 4. Cell. 2022. PMID: 35381199 Free PMC article.
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
Yofe I, Landsberger T, Yalin A, Solomon I, Costoya C, Demane DF, Shah M, David E, Borenstein C, Barboy O, Matos I, Peggs KS, Quezada SA, Amit I. Yofe I, et al. Among authors: yalin a. Nat Cancer. 2022 Nov;3(11):1404. doi: 10.1038/s43018-022-00487-7. Nat Cancer. 2022. PMID: 36376510 No abstract available.
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Barboy O, Bercovich A, Li H, Eyal-Lubling Y, Yalin A, Shapir Itai Y, Abadie K, Zada M, David E, Shlomi-Loubaton S, Katzenelenbogen Y, Jaitin DA, Gur C, Yofe I, Feferman T, Cohen M, Dahan R, Newell EW, Lifshitz A, Tanay A, Amit I. Barboy O, et al. Among authors: yalin a. Nat Cancer. 2024 Mar 1. doi: 10.1038/s43018-024-00734-z. Online ahead of print. Nat Cancer. 2024. PMID: 38429414
77 results